Biblio Discovery — Demo Discovery Service

7 results for "Datir, Rawlings P."

Showing 1–7 · 0.52 seconds · RSS

  1. Journal Article Full text

    Disengagement from HIV care and failure of second-line therapy in Nigeria: a retrospective cohort study, 2005–2017

    El Bouzidi, Kate; Murtala-Ibrahim, Fati; Kwaghe, Vivian et al.

    J Acquir Immune Defic Syndr · 2022 · English · PubMed Central

    BACKGROUND: Understanding the correlates of disengagement from HIV care and treatment failure during second-line antiretroviral therapy (ART) could inform interventions to improve clinical outcomes among people living with HIV (PLHIV). METHODS: We conducted a retrospective cohort study of PLHIV…

  2. Journal Article Full text

    Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria

    El Bouzidi, Kate; Datir, Rawlings P.; Kwaghe, Vivian et al.

    J Antimicrob Chemother · 2021 · English · PubMed Central

    BACKGROUND: Deep sequencing could improve understanding of HIV treatment failure and viral population dynamics. However, this tool is often inaccessible in low- and middle-income countries. OBJECTIVES: To determine the genetic patterns of resistance emerging in West African HIV-1 subtypes during…

  3. Journal Article Full text

    High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment

    El Bouzidi, Kate; Kemp, Steven A; Datir, Rawlings P et al.

    J Antimicrob Chemother · 2020 · English · PubMed Central

    OBJECTIVES: HIV-1 integrase inhibitors are recommended as first-line therapy by WHO, though efficacy and resistance data for non-B subtypes are limited. Two recent trials have identified the integrase L74I mutation to be associated with integrase inhibitor treatment failure in HIV-1 non-B subtypes…

  4. Journal Article Full text

    Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

    Collier, Dami A.; Ferreira, Isabella A. T. M.; Kotagiri, Prasanti et al.

    Nature · 2021 · English · PubMed Central

    Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age(1). Here we analysed immune responses following vaccination with the BNT162b2 mRNA…

  5. Journal Article Full text

    SARS-CoV-2 evolution during treatment of chronic infection

    Kemp, Steven A; Collier, Dami A; Datir, Rawlings P et al.

    Nature · 2021 · English · PubMed Central

    SARS-CoV-2 Spike protein is critical for virus infection via engagement of ACE2(1), and is a major antibody target. Here we report chronic SARS-CoV-2 with reduced sensitivity to neutralising antibodies in an immune suppressed individual treated with convalescent plasma, generating whole genome…